| 分子名 |
货号 |
物种 |
表达系统 |
产品描述 |
纯度 |
特性 |
包装/价格 |
| Rituximab
|
RIB-Y37
|
 Mouse
|
Hybridoma
|
Anti-Rituximab Antibody (AY37) (recommended for PK/PD)
|
|
|
|
| Adalimumab
|
ADB-Y23b
|
Mouse
|
HEK293
|
Anti-Adalimumab Antibody (AY23b) (recommended for PK/PD)
|
|
|
|
| Adalimumab
|
ADB-BY17c
|
Mouse
|
HEK293
|
Biotinylated Anti-Adalimumab Antibody (22E7A4A2) (recommended for PK/PD)
|
|
|
|
| Bevacizumab
|
BEB-Y10
|
Mouse
|
Hybridoma
|
Anti-Bevacizumab Antibody (AY10) (MALS verified, recommended for PK/PD)
|
|
|
|
| Trastuzumab
|
TRB-Y5b
|
Mouse
|
HEK293
|
Anti-Trastuzumab Antibody (AY5b) (recommended for PK/PD)
|
|
|
|
| Trastuzumab
|
TRB-Y1b
|
Mouse
|
HEK293
|
Anti-Trastuzumab Antibody (AY1b) (recommended for PK/PD)
|
|
|
|
| Spike RBD
|
SPD-M400a
|
 Human
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG2 (AM359b) (MALS verified)
|
|
|
|
| Spike RBD
|
SPD-M401a
|
Human
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG3 (AM359b) (MALS verified)
|
|
|
|
| Spike RBD
|
SPD-M402a
|
Human
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG4 (AM359b) (MALS verified)
|
|
|
|
| Spike RBD
|
SPD-M265
|
Human
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Broadly Neutralizing Antibody, Human IgG1 (AM359b) (MALS verified)
|
|
|
|
| Spike RBD
|
SPD-M180
|
Human
|
HEK293
|
Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180)
|
|
|
|
| Spike RBD
|
SPD-M370
|
Human
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AM110) (Delta Specific)
|
|
|
|
| Spike RBD
|
SPD-M415
|
Human
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (AS113) (Omicron Specific)
|
|
|
|
| Spike RBD
|
SPD-PLS298
|
Mouse
|
HEK293
|
HRP-Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (9A6A11) (XBB.1.5/Omicron Specific)
|
|
|
|
| Spike RBD
|
SPD-PM226
|
Mouse
|
HEK293
|
PE-Labeled Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgG1 (AM122) (Site-specific conjugation)
|
|
|
|
| Spike RBD
|
SPD-M128
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Chimeric mAb, Human IgG1 (AM128)
|
|
|
|
| Spike RBD
|
SPD-M196b
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA2 (AM130)
|
|
|
|
| Spike RBD
|
SPD-M162
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122)
|
|
|
|
| Spike RBD
|
SPD-M58P1
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgA1 (AM122)
|
|
|
|
| Spike RBD
|
SPD-M416
|
Mouse
|
Hybridoma
|
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (AS106) (Beta & Gamma Specific)
|
|
|
|
| Spike RBD
|
SPD-Y168
|
Mouse
|
Hybridoma
|
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (9A6A11) (XBB.1.5/Omicron Specific)
|
|
|
|
| Spike RBD
|
SPD-M334
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (AM334) (Beta & Gamma Specific) (MALS verified)
|
|
|
|
| Spike RBD
|
SPD-M305
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (AS113) (Omicron Specific)
|
|
|
|
| Spike RBD
|
SPD-M110
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (AS110) (Delta Specific) (MALS verified)
|
|
|
|
| Spike RBD
|
SPD-Y68
|
Mouse
|
Hybridoma
|
Anti-SARS-CoV-2 Spike RBD Broadly Antibody, Mouse IgG1 (2G7F5) (MALS verified)
|
|
|
|
| Spike RBD
|
SPD-Y170
|
Mouse
|
Hybridoma
|
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (5C5C10) (BQ.1.1/Omicron Specific)
|
|
|
|
| Spike RBD
|
SPD-Y171
|
Mouse
|
Hybridoma
|
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (5F8E1) (XBB.1.5/Omicron Specific)
|
|
|
|
| Spike RBD
|
SPD-S299
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (5C5C10) (BQ.1.1/Omicron Specific) (MALS verified)
|
|
|
|
| Spike RBD
|
SPD-M541
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgG1 (10B1A5) (BA.2&BA.4&BA.5/Omicron Specific) (MALS verified)
|
|
|
|
| Spike RBD
|
SPD-M540
|
Mouse
|
HEK293
|
Anti-SARS-CoV-2 Spike Broadly Antibody, Human IgG1 (2G7F5) (MALS verified)
|
|
|
|
Star Ribbon预染蛋白Marker蛋白质标记物是生物研究和药物开发的重要组成部分。无论是用于蛋白质电泳还是western blot，我们的预染色蛋白质标记物帮助您快速确定目标蛋白质的分子量或评估转移效率。Fc受体蛋白治疗性抗体的功效取决于Fab片段及其对目标抗原的结合活性，还取决于Fc片段及其与关键Fc受体的相互作用。因此，在抗体工程中候选物必须针对一系列受体进行测试。探索我们的重组Fc受体蛋白质的全面收藏！
膜杰作
Star Staining
